AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

The annual China Prospectors Conference kicked off on Thursday in Urumqi, Xinjiang, with industry experts calling for the ...

Zhihu's stock is undervalued despite profitability, AI innovations, and strong cash flow. Learn about share buybacks and ...

The new instalments in AMD’s MI350 chip series are faster than Nvidia counterparts and represent major gains over earlier ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

From generative AI to autonomous vehicles, European tech startups are breaking new ground — and grappling with the challenges ...

Former Rep. Chris Stewart argues that the military needs to develop an edge in AI in order to be faster and smarter in the ...

While Tesla is on the verge of starting a new chapter, Alphabet’s Waymo has been quietly providing actual paid robotaxi rides to customers in San Francisco, Phoenix, Los Angeles, and Austin, where ...

AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

Apple's iPhones were the best-selling smartphones in China last month, according to a closely followed research firm, marking a turnaround after continued market-share losses and stiff competition ...

A senior U.S. official said Huawei Technologies, China’s leading chip developer, has limited capacity to produce artificial intelligence chips this year, suggesting that U.S. restrictions on the ...

AI tools are reducing the need for new hires, especially in engineering, marketing, and customer service. The headlines say ...